Baker Bros. Advisors LP Sarepta Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $7.74 Million - $10.9 Million	-123,456 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $9.54 Million - $12.3 Million	123,456 New	123,456 $11.1 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $4.07 Million - $5.09 Million	-58,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $4.24 Million - $9.92 Million	58,700 New	58,700 $4.38 Million

470

79.3M

4.23M

1.21M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.